Skip to main content
Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ATAC Projects
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Contact
Imprint
Privacy Policy
Disclaimer
Supplier & partners
Contact
English
Deutsch
Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ATAC Projects
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Scientific posters
AACR Annual Meeting 2024
Liver toxicity of amanitin-based antibody drug conjugates (ATAC®s) is caused by unspecific uptake of the ATAC® into liver cells
AACR Annual Meeting 2024
HDP-101: The Anti-BCMA Antibody-Drug Conjugate HDP-101 with a Novel Amanitin Payload Shows Promising Initial First in Human Results in Relapsed Multiple Myelom
AACR Annual Meeting 2024
HDP-102 - a CD37-targeting Amanitin-based-ADC for the treatment of Non-Hodgkin Lymphoma (NHL) - non-clinical data package
AACR Annual Meeting 2024
Multimeric linker exatecan-based ADC targeting Guanylyl cyclase C (GCC) as novel therapeutic modality for treatment of colorectal cancer
ASH Annual Meeting 2023
HDP-101: An Anti-BCMA Antibody-Drug Conjugate with a Novel Payload Amanitin in Patients with Relapsed Multiple Myeloma, Initial Findings of the First in Human Study
PEGS Boston 2023
In vivo detoxification of Amatoxin-based ADCs (ATACs®) by “Click” chemistry
AACR Annual Meeting 2023
Subcutaneous dosing increases the therapeutic index of Amatoxin-based ADCs
AACR Annual Meeting 2023
Amanitin-based ADCs targeting Guanylyl cyclase C (GCC) as novel therapeutic modality for treatment of colorectal cancer
ASH Annual Meeting 2022
HDP-101, an Anti-BCMA Antibody-Drug Conjugate with a Novel Payload Amanitin in Patients with Relapsed Multiple Myeloma, Initial Findings of the First in Human Study
AACR Annual Meeting 2022
Treatment with ATAC® induces tolerability in preclinical animal models without triggering tolerance
AACR Annual Meeting 2022
ATACs® induce immunogenic cell death and improve the efficacy of immune checkpoint inhibitors
AACR Annual Meeting 2021
Combination of ATACs with Immune checkpoint inhibitors shows synergistic therapeutic effect
AACR Annual Meeting 2021
Preclinical evaluation of anti-CD37 Antibody-Targeted Amanitin Conjugates (ATAC) in B-cell malignancies
AACR Annual Meeting 2021
Amanitin-based ADCs targeting PSMA as novel therapeutic modality for prostate cancer therapy